Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

Small to mid-sized enterprises and academic medical centers will have access to scalable and flexible solutions Cytiva, a global life sciences leader, and NecstGen, aim to accelerate the development of new cell and gene therapies globally via a strategic collaboration. Cytiva will provide its technologies, services, and solutions to NecstGen, and both organizations will share their [...]

Zetta Genomics gains £2.5m seed funding to realise the power of genomic data in precision medicine

Nina Capital, APEX Medical and Cambridge Enterprise invest in transformational open-source data technology – to deliver precision medicine at scale University of Cambridge technology spin-out Zetta Genomics announces that is has raised £2.5 million in new seed funding. The successful round secures leading global Venture Capital (VC) investment in the company’s XetaBase platform – a [...]

Qlucore appoints new CFO

Cecilia Grotte takes up her position in Spring 2022 Swedish Software company Qlucore, listed on Nasdaq First North, today announces that it has appointed Cecilia Grotte with the intention to install her as CFO to take over from interim CFO Anders Bergstrand. Cecilia Grotte’s previous employment was as CFO at SimFAS Sweden. Her employment with [...]

Promega Earns a 2022 Top Workplaces USA Award

Biotech company recognized for culture supporting work-life balance Madison, WI USA. -- Promega Corporation was recognized today as a top place to work in the US with a 2022 Top Workplaces USA award. Companies earn a place on the Top Workplaces USA list based solely on employee engagement surveys compiled by research firm Energage. More [...]

Polyplus Acquires e-Zyvec to Expand Expertise in plasmid DNA Vector Engineering

Polyplus today announces the acquisition of E-Zyvec with a focus on expanding process economics optimization efforts for cell and gene therapy developers and manufacturers. Strasbourg, France – Polyplus, a leading provider of upstream process solutions for advanced biologic and cell and gene therapy production from research to commercial grade, today announces the acquisition of e-Zyvec, [...]

AZENTA LIFE SCIENCES COMPLETES SALE OF SEMICONDUCTOR SOLUTIONS GROUP BUSINESS TO THOMAS H. LEE PARTNERS

CHELMSFORD, Mass. -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has completed the previously announced sale of the company's Semiconductor Solutions Group business (or "automation business") to Thomas H. Lee Partners ("THL") for $3.0 billion in cash, subject to adjustments for working capital and other items. Proceeds from the sale, net of taxes, fees and adjustments, are [...]

Lightspeed Microscopy, Inc. Rebrands as Alpenglow Biosciences

SEATTLE -- Lightspeed Microscopy, Inc., developers of an innovative end-to-end 3D spatial biology platform, has announced today that the company will begin operating under the name Alpenglow Biosciences, effective immediately. The company’s ownership and staff remain unchanged. CEO, Nicholas Reder, MD, MPH stated “Our rebranding as Alpenglow Biosciences represents the evolution of our company towards [...]

Congenica 3.3 improves genomic data analysis and automates workflow

Data interpretation is by far the most time-consuming and resource-intensive step of the NGS workflow. Any time savings that can be found have a significant impact on overall costs and sample throughput. The release of Congenica v3.3, the first of our product releases for 2022, enables our customers to benefit from the use of Congenica’s [...]

Biosero Collaborates with Araceli Biosciences for High-Content Analysis

Alliance pairs ultra-high-speed cell imaging technology with industry-leading lab automation solution SAN DIEGO -- Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a collaboration with Araceli Biosciences that will allow scientists to integrate Araceli’s Endeavor™ high-speed imaging platform into automated workflows controlled by Biosero’s Green Button Go® software suite. The Endeavor platform offers [...]

BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

Informatics Capabilities Help Expand BD Data Analytics Capabilities and Understanding of Cancer and Other Chronic Diseases FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of Cytognos, a privately held company headquartered in Salamanca, Spain, specializing in flow cytometry solutions [...]

Access IBO on Knowledge Center